Ventyx Biosciences (VTYX) Stock Statistics & Valuation Metrics

Ventyx Biosciences has a market cap or net worth of $213.93M. The enterprise value is -$46.30M.

Ventyx Biosciences has 71,308,520 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ventyx Biosciences’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -55.83%.

The current PE Ratio of Ventyx Biosciences is ―. Ventyx Biosciences’s PEG ratio is ―.

In the last 12 months, Ventyx Biosciences had revenue of 0.00 and earned -135.12M in profits. Earnings per share was -1.97.

In the last 12 months, operating cash flow was -105.70M and capital expenditures -64.00K, giving a free cash flow of -105.77M billion.

Ventyx Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Ventyx Biosciences upcoming earnings date is Nov 12, 2025, After Close (Confirmed).

Ventyx Biosciences as a current ratio of 17.97, with Debt / Equity ratio of 4.92%

In the past 12 months, Ventyx Biosciences has paid 0.00 in taxes.

Ventyx Biosciences EV to EBITDA ratio is -1.00, with an EV/FCF ratio of -1.02.

Ventyx Biosciences has $208.96M in cash and marketable securities with $10.29M in debt, giving a net cash position of -$198.66M billion.

Gross margin is -18.23%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Ventyx Biosciences is $11.40, which is 11.43% higher than the current price. The consensus rating is Moderate Buy